Uptake of COVID-19 vaccination in people with blood cancer: Population-level cohort study of 12 million patients in England.

ABSTRACT:

Background

People with blood cancers have increased risk of severe outcomes from COVID-19 and were prioritised for vaccination.

Methods

Individuals in the QResearch database aged 12 years and above on 1st December 2020 were included in the analysis. Kaplan-Meier analysis described time to COVID-19 vaccine uptake in people with blood cancer and other high-risk disorders. Cox regression was used to identify factors associated with vaccine uptake in people with blood cancer.

Results

The analysis included 12,274,948 individuals, of whom 97,707 had a blood cancer diagnosis. 92% of people with blood cancer received at least one dose of vaccine, compared to 80% of the general population, but there was lower uptake of each subsequent vaccine dose (31% for fourth dose). Vaccin

SUBMITTER: Hirst J 

PROVIDER: S-EPMC9916184 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature